DAVITA INC. (DVA) FY2026 YTD Q3 P&L / Income Statement
Published · Updated Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)
Revenue by Business Segment (2 categories)
Swipe to see the full flow
Chart details
DAVITA INC. (DVA) FY2026 YTD Q3 P&L / Income Statement
Income statement for 2026-01-01 through 2026-09-30. View: Business segment (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenues
- 10,547,758,000 US dollars
- Total operating expenses
- 8,987,610,000 US dollars
- Operating income
- 1,560,148,000 US dollars
- Other income (expense), net (calculated)
- negative 425,197,000 US dollars
- Income before income taxes
- 1,134,951,000 US dollars
- Income tax expense
- 247,304,000 US dollars
- Net income
- 887,647,000 US dollars
- U. S. Dialysis And Related Lab Services
- 8,950,162,000 US dollars
- Other Operating Segment
- 1,597,596,000 US dollars
- Patient care costs
- 7,185,305,000 US dollars
- General and administrative
- 1,254,069,000 US dollars
- Depreciation and amortization
- 510,825,000 US dollars
- Equity investment income, net
- negative 24,765,000 US dollars
- Goodwill and other asset impairment charges
- 62,176,000 US dollars
Chart connections
- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to DAVITA INC.: $685.86 M; to noncontrolling interests: $201.79 M.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
